TEV-53275
/ Teva
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
May 27, 2022
A Study to Test if TEV-53275 is Effective in Relieving Asthma
(clinicaltrials.gov)
- P2 | N=97 | Terminated | Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Trial completion date: Jul 2022 ➔ Apr 2022 | Active, not recruiting ➔ Terminated; Stopped for strategic reasons
Trial completion date • Trial termination • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
April 22, 2022
A Study to Test if TEV-53275 is Effective in Relieving Asthma
(clinicaltrials.gov)
- P2 | N=97 | Active, not recruiting | Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Recruiting ➔ Active, not recruiting | N=300 ➔ 97
Enrollment change • Enrollment closed • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
April 19, 2021
A Study to Test if TEV-53275 is Effective in Relieving Asthma
(clinicaltrials.gov)
- P2; N=300; Recruiting; Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
New P2 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
1 to 3
Of
3
Go to page
1